Elixxer Ltd.

ELXR

CA28660W2004

Investment Management & Fund Operators

Delayed Toronto S.E. Other stock markets 03:09:04 2022-05-10 pm EDT			5-day change	1st Jan Change
1.15 ^CAD	-.--%		-.--%	-.--%

2023	Elixxer Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Elixxer Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Elixxer Ltd. Announces Resignation of Mazen Haddad as a Director

May 18, 2021 at 11:41 am EDT

Elixxer Ltd. announced that, effective immediately, Mazen Haddad has resigned as a director of the Company.

Latest news about Elixxer Ltd.

Elixxer Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 24	CI
Elixxer Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Nov. 09	CI
Elixxer Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	Nov. 06	CI
Elixxer Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-07-27	CI
Elixxer Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-23	CI
Tranche Update on Elixxer Ltd.'s Equity Buyback Plan announced on July 6, 2021.	22-09-06	CI
Tranche Update on Elixxer Ltd.'s Equity Buyback Plan announced on July 6, 2021.	22-09-06	CI
Elixxer Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-06	CI
Elixxer Ltd.'s Equity Buyback announced on July 6, 2021, has expired with 430,731 shares, representing 3.90% for CAD 0.58 million.	22-08-07	CI
Tranche Update on Elixxer Ltd.'s Equity Buyback Plan announced on July 6, 2021.	22-05-29	CI
Elixxer Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-29	CI
Elixxer Ltd. Auditor Raises 'Going Concern' Doubt	22-05-09	CI
Tranche Update on Elixxer Ltd.'s Equity Buyback Plan announced on July 6, 2021.	22-05-09	CI
Elixxer Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-09	CI
Elixxer Up 7.5% after Reporting Binding Offer to Sell Viridi Stake for $1 Million	22-03-29	MT
Elixxer Ltd. Announces Amended Secured Loan with AIP Convertible Private Debt Fund L.P	22-02-22	CI
Elixxer Ltd. Announces Board Changes	21-11-26	CI
Tranche Update on Elixxer Ltd.'s Equity Buyback Plan announced on July 6, 2021.	21-11-25	CI
Elixxer Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-25	CI
Elixxer Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-27	CI
Elixxer : Plans to Consolidate Common Shares; Falls 33.3%	21-08-24	MT
Elixxer : Falls 20% after Reporting Approval of Share Buyback	21-08-04	MT
Elixxer Seeks Bigger Acquisitions	21-07-30	CI
Elixxer Ltd. announces an Equity Buyback for 560,508 shares, representing 5% of its issued share capital.	21-07-06	CI
Elixxer Ltd.'s Board intends to launch an Equity Buyback.	21-07-06	CI

Elixxer Ltd. is a Canada-based investment company. The Company has investments and activities in the legal cannabis sector. The Company is focused on investing opportunities in various sectors, with a priority on growth companies that are past the start-up phase.

Sector

Investment Management & Fund Operators

Calendar

2024-11-20 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
ELIXXER LTD.	-.--%	9.56M
UBS GROUP AG	+9.16%	101B
BROOKFIELD CORPORATION	+11.67%	67.41B
APOLLO GLOBAL MANAGEMENT, INC.	+23.96%	66.1B
BANK OF NEW YORK MELLON CORPORATION (THE)	+14.52%	44.58B
AMERIPRISE FINANCIAL, INC.	+14.85%	43.37B
3I GROUP PLC	+18.26%	35.13B
T. ROWE PRICE GROUP INC.	+9.42%	26.31B
STATE STREET CORPORATION	-2.41%	22.77B
PRINCIPAL FINANCIAL GROUP, INC.	+4.28%	19.23B